Search

everythinglearnresearchcommunity

for

Search:↓

The treatment is safe and shows promise for metastatic breast cancer.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Axitinib treatment turned a man's grey hair back to black.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Boosting certain cell signals can prevent hair loss from cancer treatments.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.